Acute compartment syndrome of hand resulting from radiographic contrast iohexol extravasation
Kolar Vishwanath Vinod1★, Rampelli Shravan1, Radhakrishnan Shrivarthan1, Pedapati Radhakrishna1★ Corresponding author
- 1Tarun Kumar Dutta Department of General Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
CORRESPONDENCE
Kolar Vishwanath Vinod
Tarun Kumar Dutta Department of General Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Received: 13-07-2015; Revised: 12-11-2015; Accepted: 04-01-2016.
Volume 7, Issue 1 · pp. 44–47 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.179353
ABSTRACT
Intravenous (IV) administration of iodinated contrast agents (ICAs) is frequently employed for image enhancement while performing radiographic studies such as computed tomography and angiography. Complications related to IV administration of ICAs such as immediate hypersensitivity reactions and nephrotoxicity are well‑known. However, severe skin and soft tissue injuries and acute compartment syndrome resulting from contrast extravasation are rare. This is especially so with small volume extravasation of a low osmolar, nonionic ICA such as iohexol. Here, we report a 63‑year‑old woman who developed acute compartment syndrome of left hand following iohexol extravasation and had swelling, blistering, cutaneous and soft tissue necrosis. She underwent fasciotomy for acute compartment syndrome of hand and later surgical debridement of necrotic skin and soft tissues was carried out. Clinical pharmacology of ICAs, extravasation injuries following their IV administration, their management and measures to reduce them are discussed in brief.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Vinod, K. V., Shravan, R., Shrivarthan, R., & Radhakrishna, P. (2016). Acute compartment syndrome of hand resulting from radiographic contrast iohexol extravasation. Journal of Pharmacology and Pharmacotherapeutics, 7(1), 44–47. https://doi.org/10.4103/0976-500X.179353